Proteomics in biomarker discovery and drug development

QY He, JF Chiu - Journal of cellular biochemistry, 2003 - Wiley Online Library
Proteomics is a research field aiming to characterize molecular and cellular dynamics in
protein expression and function on a global level. The introduction of proteomics has been …

[HTML][HTML] Proteomics in translational cancer research: toward an integrated approach

JE Celis, P Gromov - Cancer cell, 2003 - cell.com
Proteomics provides powerful tools for the study of clinically relevant samples in the context
of translational cancer research. Here we briefly review applications of gel-based …

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung

M Raponi, Y Zhang, J Yu, G Chen, G Lee, JMG Taylor… - Cancer research, 2006 - AACR
Non–small-cell lung cancers (NSCLC) compose 80% of all lung carcinomas with squamous
cell carcinomas (SCC) and adenocarcinoma representing the majority of these tumors …

Protein profiles associated with survival in lung adenocarcinoma

G Chen, TG Gharib, H Wang… - Proceedings of the …, 2003 - National Acad Sciences
Morphologic assessment of lung tumors is informative but insufficient to adequately predict
patient outcome. We previously identified transcriptional profiles that predict patient survival …

miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia–rearranged leukemia

P Chen, C Price, Z Li, Y Li, D Cao… - Proceedings of the …, 2013 - National Acad Sciences
MicroRNAs (miRNAs), small noncoding RNAs that regulate target gene mRNAs, are known
to contribute to pathogenesis of cancers. Acute myeloid leukemia (AML) is a group of …

Ultrasensitive detection of dual cancer biomarkers with integrated CMOS-compatible nanowire arrays

N Lu, A Gao, P Dai, H Mao, X Zuo, C Fan… - Analytical …, 2015 - ACS Publications
A direct, rapid, highly sensitive and specific biosensor for detection of cancer biomarkers is
desirable in early diagnosis and prognosis of cancer. However, the existing methods of …

Mass spectrometry‐based proteomics: The road to lung cancer biomarker discovery

P Indovina, E Marcelli, F Pentimalli… - Mass spectrometry …, 2013 - Wiley Online Library
Lung cancer is the leading cause of cancer death in men and women in Western nations,
and is among the deadliest cancers with a 5‐year survival rate of 15%. The high mortality …

Doubly penalized Buckley–James method for survival data with high-dimensional covariates

S Wang, B Nan, J Zhu, DG Beer - Biometrics, 2008 - academic.oup.com
Recent interest in cancer research focuses on predicting patients' survival by investigating
gene expression profiles based on microarray analysis. We propose a doubly penalized …

[HTML][HTML] Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas

G Chen, H Wang, TG Gharib, CC Huang… - Molecular & Cellular …, 2003 - ASBMB
We examined the expression of oncoprotein 18 (Op18) in 93 lung adenocarcinomas and 10
uninvolved lung samples using quantitative two-dimensional PAGE analysis with …

Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas

CT Miller, G Chen, TG Gharib, H Wang, DG Thomas… - Oncogene, 2003 - nature.com
The C-CRK gene, cellular homolog of the avian v-crk oncogene, encodes two alternatively
spliced adaptor signaling proteins, CRKI (28 kDa) and CRKII (40 kDa). Both CRKI and CRKII …